| Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound SA Charman, WN Charman, MC Rogge, TD Wilson, FJ Dutko, CW Pouton Pharmaceutical research 9, 87-93, 1992 | 627 | 1992 |
| Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses SC Chien, MC Rogge, LG Gisclon, C Curtin, F Wong, J Natarajan, ... Antimicrobial agents and chemotherapy 41 (10), 2256-2260, 1997 | 303 | 1997 |
| Effect of food and a monoglyceride emulsion formulation on danazol bioavailability WN Charman, MC Rogge, AW Boddy, BM Berger The Journal of Clinical Pharmacology 33 (4), 381-386, 1993 | 176 | 1993 |
| Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses JT Lettieri, MC Rogge, L Kaiser, RM Echols, AH Heller Antimicrobial agents and chemotherapy 36 (5), 993-996, 1992 | 165 | 1992 |
| Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis H Lee, HC Kimko, M Rogge, D Wang, I Nestorov, CC Peck Clinical Pharmacology & Therapeutics 73 (4), 348-365, 2003 | 141 | 2003 |
| A novel PEGylated interferon beta‐1a for multiple sclerosis: safety, pharmacology, and biology X Hu, L Miller, S Richman, S Hitchman, G Glick, S Liu, Y Zhu, M Crossman, ... The Journal of Clinical Pharmacology 52 (6), 798-808, 2012 | 129 | 2012 |
| Targeting RNA: a transformative therapeutic strategy W Yin, M Rogge Clinical and translational science 12 (2), 98-112, 2019 | 124 | 2019 |
| Protein therapeutics: new applications for pharmacogenetics C Krejsa, M Rogge, W Sadee Nature Reviews Drug Discovery 5 (6), 507-521, 2006 | 115 | 2006 |
| Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects SC Chien, AT Chow, J Natarajan, RR Williams, FA Wong, MC Rogge, ... Antimicrobial agents and chemotherapy 41 (7), 1562-1565, 1997 | 105 | 1997 |
| In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug MG Woods, GD Diana, MC Rogge, MJ Otto, FJ Dutko, MA McKinlay Antimicrobial agents and chemotherapy 33 (12), 2069-2074, 1989 | 86 | 1989 |
| Methods of treating pain and inflammation in neuronal tissue using antagonists of IL-31, IL31Ra and/or OSMRb Y Yao, J Bilsborough US Patent 7,638,126, 2009 | 79 | 2009 |
| Best practices for the use of itraconazole as a replacement for ketoconazole in drug–drug interaction studies L Liu, A Bello, MJ Dresser, D Heald, SF Komjathy, E O'Mara, M Rogge, ... The Journal of Clinical Pharmacology 56 (2), 143-151, 2016 | 75 | 2016 |
| Comparative Pharmacokinetics and Pharmacodynamics of Two Recombinant Human Interferon Beta-1a (IFN [beta]-1a) Products Administered Intramuscularly in Healthy Male and Female … J Alam, S Goelz, P Rioux, J Scaramucci Pharmaceutical research 14 (4), 546, 1997 | 75 | 1997 |
| Comparative Pharmacokinetics and Pharmacodynamics of Two Recombinant Human Interferon Beta-1a (IFN [beta]-1a) Products Administered Intramuscularly in Healthy Male and Female … J Alam, S Goelz, P Rioux, J Scaramucci Pharmaceutical research 14 (4), 546, 1997 | 75 | 1997 |
| Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single‐and double‐peak phenomena in the plasma profiles WN Charman, MC Rogge, AW Boddy, WH Barr, BM Berger The Journal of Clinical Pharmacology 33 (12), 1207-1213, 1993 | 75 | 1993 |
| Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers A Munafo, A Priestley, I Nestorov, J Visich, M Rogge European journal of clinical pharmacology 63, 647-656, 2007 | 73 | 2007 |
| Bioavailability of hydrochlorothiazide from tablets and suspensions RB Patel, UR Patel, MC Rogge, A Selen, PG Welling, VP Shah, ... Journal of pharmaceutical sciences 73 (3), 359-361, 1984 | 69 | 1984 |
| Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers. W Meier, A Gill, M Rogge, R Dabora, GR Majeau, FB Oleson, WE Jones, ... Therapeutic Immunology 2 (3), 159-171, 1995 | 65 | 1995 |
| Activity of levofloxacin in a murine model of tuberculosis SP Klemens, CA Sharpe, MC Rogge, MH Cynamon Antimicrobial agents and chemotherapy 38 (7), 1476-1479, 1994 | 65 | 1994 |
| Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists Y Yao, J Bilsborough US Patent 7,514,077, 2009 | 62 | 2009 |
